Skip to content

Comparison of Paracetamol and haldi in arthritis of knee joints

Randomized controlled study to compare the efficacy and safety of Biocurcumin and Paracetamol in patients of osteoarthritis of Knee joints

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2017/02/007962
Enrollment
192
Registered
2017-02-27
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M179- Osteoarthritis of knee, unspecified Health Condition 2: null- Patients of osteoarthritis of knee joints

Interventions

Intervention1: Biocurcumin: Cap 500mg twice daily orally for 6 weeks Control Intervention1: Paracetamol: 650mg thrice daily orally for 6 weeks

Sponsors

Maulana Azad Medical college
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients of knee osteoarthritis(Diagnosis based on ACR Criteria) , age 40 - 80 years 2.Patient has not received any NSAIDs or any other analgesic within 24 hours 3.Patients with chronic knee pain (i.e., knee pain at least every other day during the month preceding inclusion) 4.Patients with radiologic knee osteoarthritis (Kellgren-Lawrence grade 2-4) 5.Patients capable of comprehending the study instructions.

Exclusion criteria

Exclusion criteria: 1.Patients with osteoarthritis linked to a metabolic arthropathy 2.Patients with Chondromatosis or villonodular synovitis of the knee 3.History of recent trauma ( 4.Patients who have Inflammatory flare (night pain, joint effusion) 5. Patients who had Corticosteroids injection in the previous month and Hyaluronic acid injection in the evaluated knee during the previous 6 months 6. Patient suffering from serious comorbid conditions(liver failure, kidney failure, uncontrolled cardiovascular diseases) 7. Pregnant patients or breastfeeding women 8. Patients allergic to Ibuprofen or turmeric

Design outcomes

Primary

MeasureTime frame
Change from baseline in the WOMAC� Osteoarthritis� Index pain subscale score at week 6Timepoint: week 6

Secondary

MeasureTime frame
Change from baseline in the WOMAC� Osteoarthritis� Index stiffness and physical functionscores at week 6.Timepoint: week 6

Countries

India

Contacts

Public ContactDr Bhupinder singh

Maulana Azad Medical College

drbskalra@gmail.com9968604487

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 24, 2026